UNAUDITED PRO FORMA CONDENSED CONSOLIDATED FINANCIAL STATEMENTSBoston Scientific Corp • March 17th, 2006 • Surgical & medical instruments & apparatus
Boston Scientific Corporation and Guidant Corporation entered into an Agreement and Plan of Merger, dated as of January 25, 2006, among Boston Scientific, Galaxy Merger Sub, a wholly owned subsidiary of Boston Scientific, and Guidant, that is described in the joint proxy statement/prospectus which is included in Boston Scientific’s registration statement on Form S-4, as amended (Registration no. 333-131608). Under the terms of the merger agreement, Galaxy Merger Sub will be merged with and into Guidant, with Guidant surviving the merger as a wholly owned subsidiary of Boston Scientific. In addition, Boston Scientific and Abbott Laboratories entered into a Transaction Agreement, dated as of January 8, 2006 as amended by Amendment No. 1 and Amendment No. 2, each dated as of January 16, 2006, and Amendment No. 3 dated as of February 22, 2006, pursuant to which Abbott agreed to buy the Guidant vascular intervention and endovascular solutions businesses for an initial payment of $4.1 billio
